This Government Contract opportunity from Department Of Defense was posted on July 23, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Packaging, Labeling, and Barcoding Services for Medical Supplies

Closed

Federal

Submission Closed07/29/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325999

DIBBS

Medical Supply Packaging and Labeling ServicesThe Medical Supply Packaging and Labeling Services subcontract, managed by the Defense Logistics Agency under the Department of Defense, focuses on the secondary packaging, labeling, and kitting of pharmaceutical products for military logistics. The scope of work requires strict adherence to traceable shipping requirements and the precise application of critical identifiers, including CAGE codes, National Drug Codes, and part numbers. Operating under NAICS code 325999, this agreement ensures that medical supplies are properly processed and documented for secure distribution within the military supply chain. The contract emphasizes compliance and accuracy in labeling to maintain the integrity and traceability of pharmaceutical assets during transit and storage.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling Services

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Packaging and Unit of Issue ComplianceThe contract entails the repackaging and labeling of Adenosine Injection to comply with the Defense Logistics Agency’s ANSI X12 unit of issue standards, NSN marking requirements, and federal supply system protocols. All work must be performed in a sterile environment to maintain product integrity and regulatory compliance, ensuring the medication meets stringent military and federal pharmaceutical standards. The activity is classified under NAICS code 325999 and is structured as a subcontract under the Department of Defense, with performance tied to the DLA’s logistical and supply chain mandates. The contract was posted in August 2026 and is associated with the award SPE2DX25D8022, with delivery order SPE2D926F8091, indicating its integration into the broader defense supply network.

Defense Logistics Agency

POSTED

DEADLINE

Packaging and Labeling Compliance for DLA ContractsThis contract mandates strict adherence to Defense Logistics Agency standards for the packaging and labeling of pharmaceutical products, ensuring full compliance with Department of Defense requirements. Key obligations include accurate marking of Blocks 1 and 2 on all packaging, proper application of NSN and NDC labels, and fulfillment of all DoD-specific packaging specifications to guarantee interoperability and traceability within military supply chains. The subcontract is categorized under NAICS code 325999 and is issued under the Defense Logistics Agency, with performance tied to the broader Department of Defense framework. All activities must align with established protocols to maintain qualification for DLA contracts, and noncompliance may result in rejection of delivered goods or contract penalties. The solicitation, dated August 9, 2026, is accessible through the DIBBS portal under contract number SPE2DX25D8022 and delivery order SPE2D926F8118.

Defense Logistics Agency

POSTED

DEADLINE

Medical Product Packaging and Labeling ServicesThe contract requires the provision of packaging and labeling services for pharmaceutical shipments that fully comply with Department of Defense standards, specifically utilizing DLA-approved methods to apply critical identifiers such as NSN, CAGE, TCN, and RDD markings. All labeling must be durable, traceable, and permanently affixed to ensure accurate inventory management and logistics tracking throughout the defense supply chain. The work must adhere strictly to DLA specifications for material selection, print clarity, and environmental resilience to withstand handling in military operations. This subcontract under the broader Defense Logistics Agency framework pertains to the NAICS code 325999 for other pharmaceutical and medicine manufacturing services, supporting the Department of Defense’s logistical needs for medical supplies. The contract is tied to the award SPE2DX25D8022 and delivery order SPE2D926F8039, with performance obligations centered around compliance, consistency, and reliability in marking and packaging practices. No specific geographic performance location is listed, indicating that work may occur at multiple secure facilities approved for defense contract handling, with all outputs subject to rigorous quality assurance verification prior to distribution.

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling Services

Defense Logistics Agency

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling ServicesThe contract encompasses the packaging and labeling of pharmaceutical products to meet Defense Logistics Agency specifications, ensuring full compliance with military and federal standards. All products must be labeled with mandatory identifiers including the National Stock Number, National Drug Code, contract number, and tracking information to support end-to-end supply chain visibility and accountability. The work is structured as a subcontract under the NAICS code 325999 and is associated with the Department of Defense, specifically managed by the Defense Logistics Agency. Packaging procedures must align with DLA requirements for durability, regulatory adherence, and logistical compatibility across military distribution channels. The contract was posted on August 9, 2026, and is linked to the procurement reference SPE2DX25D8022 with delivery order SPE2D926F8113.

Defense Logistics Agency

POSTED

DEADLINE

Medical Product Packaging and Labeling

Defense Logistics Agency

POSTED

DEADLINE

Medical Supply Sterilization Services

Nac Federal Supply Schedule (36F797)

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling

Defense Logistics Agency

POSTED

DEADLINE

DLA-Compliant Packaging and LabelingThe contract requires the packaging and labeling of pharmaceutical products in strict compliance with Defense Logistics Agency standards, ensuring all items are properly marked with mandatory identifiers including the National Stock Number, National Drug Code, CAGE code 1LEZO, and TCN W50YF262160118. This subcontract is tied to the Department of Defense and falls under the NAICS code 325999 for other pharmaceutical and medicine manufacturing, emphasizing precision in adherence to federal labeling protocols for military medical supply chains. The work must be performed in accordance with DLA marking specifications, and while the exact performance location is unspecified, the contract is linked to the official DIBBS award record with contract SPE2DX25D9900 and delivery order SPE2DP26F8714, indicating the procurement was initiated through a government-wide system for defense logistics. The solicitation was posted on August 5, 2026, suggesting this is a forward-looking requirement for future fulfillment.

Defense Logistics Agency

POSTED

DEADLINE

Medical Product Packaging and Labeling Services

Defense Logistics Agency

POSTED

about 1 month ago

DEADLINE

N/A

AI Contract Overview

The contract requires comprehensive packaging, labeling, and barcoding services for medical and pharmaceutical items in strict compliance with Defense Logistics Agency standards. All items must be marked with specified identifiers including National Stock Number, Contract Line Item Number, National Drug Code, Part Number, and OPI:M codes to ensure accurate tracking and distribution through military supply chains. The work must be performed at the designated place of performance in Fort Bragg, North Carolina, with adherence to stringent specifications for accuracy, durability, and regulatory compliance. This is a subcontract opportunity under NAICS code 325999, issued by the Department of Defense’s Medical Supply Chain Pharm FSA, with a response deadline of July 29, 2026, and no set-aside provisions specified.